What changed
$VEEV — WATCHLIST 📊
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.
🎯 Q2 2026 | Rev $1B | EPS $2.24 vs $2.14 🟢
💡 Consensus expects continued steady growth and margin expansion. However, the stock's valuation at ~28x forward sales already discounts much of this, while risks from life sciences budget tightening and competition are underappreciated. Upside surprise from the recent beat may have exhausted near-term catalysts.
📉 Reward/risk: 2.35:1
🏢 Business Quality: 8/10
📊 Valuation: rich — At a $100B market cap, P/S ~28x forward revenue, above historical averages and peer median for similar SaaS providers.
🔮 Catalyst: Q2 FY2027 earnings release (quarter ending July 31,2026)
📊 Our read: WATCHLIST. Full analysis →
https://stockduty.xyz/s/VEEV0624
Why it matters
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.